iwCAR-T Session I: CAR-T therapy in lymphoma and the role of bispecific antibodies episode artwork

EPISODE · May 11, 2023 · 15 MIN

iwCAR-T Session I: CAR-T therapy in lymphoma and the role of bispecific antibodies

from VJHemOnc Podcast · host VJHemOnc

The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April, 2023, and brought together world-leading experts in CAR-T therapy as they discussed the latest in the field. In this podcast series, you will gain an insight into the sessions that took place at this year’s meeting, which covered the latest updates in CAR-T therapy in chronic lymphocytic leukemia (CLL), lymphoma, acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and more. In this podcast, you will hear from Loretta Nastoupil, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, Tycel Phillips, MD, City of Hope, Duarte, CA, and Mazyar Shadman, MD, Fred Hutchinson Cancer Research Center, Seattle, WA, who share some updates on CAR-T therapy in lymphoma, and further discuss where bispecific antibodies may fit in the treatment landscape.

Episode metadata supplied by the publisher feed · Published May 11, 2023

Embed this episode

Ready to play

iwCAR-T Session I: CAR-T therapy in lymphoma and the role of bispecific antibodies

0:00 15:18

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of VJHemOnc Podcast?

This episode is 15 minutes long.

When was this VJHemOnc Podcast episode published?

This episode was published on May 11, 2023.

Can I download this VJHemOnc Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!